A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2006
10/25/2006	CN1850148A Medicine for increasing bird's immunity and treating immunity-inhibiting diseases, and preparing medicine therefor
10/25/2006	CN1850128A Pine pollen composition with beauty nourish function to face, intensifying immunity of body
10/25/2006	CN1850070A Quercetin solid liposome nano particle preparation and its preparing method
10/25/2006	CN1849927A Health-care product for relieving fatigue and intensifying immunity and preparing method
10/25/2006	CN1849916A Formula of nutritious porridge and making method
10/25/2006	CN1281748C Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
10/25/2006	CN1281747C i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281593C Immune regulation and biological therapeutic function of benzo-isoselenazole derivatives
10/25/2006	CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006	CN1281585C Cyclic diamine compounds having fused-ring groups
10/25/2006	CN1281283C Procedure and composition of treatment and/or care of eye
10/25/2006	CN1281259C Leadless plaster medium for Chinese medicine and preparing method
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125890 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125708 Composition comprising a Lactobacillus pentosus strain and uses thereof
10/24/2006	US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006	US7125696 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	US7125564 Glycyrrhizin complex
10/24/2006	CA2310398C 5h-pyrano[2,3-d:6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity
10/24/2006	CA2261848C Cell adhesion inhibitors
10/24/2006	CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/24/2006	CA2195663C Dihydrobenzofuranes
10/19/2006	WO2006110577A2 Use of fril proteins for reducing the production of pro-inflammatory cytokines
10/19/2006	WO2006110088A1 Selection and use of lactic acid bacteria for reducing inflammation in mammals
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109737A1 Pranlukast hydrate-containing preparation having relieved bitterness
10/19/2006	WO2006109633A1 Substituted indole compound
10/19/2006	WO2006109186A2 Early endosome neutralising compouds as vaccine adjuvants
10/19/2006	WO2006109071A2 Vaccine against burkholderia infections
10/19/2006	WO2006108670A2 Use of cd25 antibodies in immunotherapy
10/19/2006	WO2006108572A2 Novel crystalline pharmaceutical product
10/19/2006	WO2006108424A2 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
10/19/2006	WO2006108241A1 Immunomodulating compositions and uses therefor
10/19/2006	WO2006094134A3 Kim-1 antibodies for treatment of th2-mediated conditions
10/19/2006	WO2006030220A9 Compositions monovalent for cd40l binding and methods of use
10/19/2006	WO2006023791A3 Methods and compositions for treating allergic inflammation
10/19/2006	US20060235231 Histone deacetylase inhibitors
10/19/2006	US20060235201 Enduring T cell response
10/19/2006	US20060235058 Substituted 5-membered ring compounds and their use
10/19/2006	US20060235057 Phenyl compounds
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006	US20060234991 Combinations for the treatment of immunoinflammatory disorders
10/19/2006	US20060234990 Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
10/19/2006	US20060234980 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
10/19/2006	US20060234955 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
10/19/2006	US20060234937 Modulation of angiogenesis
10/19/2006	US20060234925 Embryo implantation inhibitor
10/19/2006	US20060234917 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation
10/19/2006	US20060234344 Protein kinases
10/19/2006	US20060234342 Human DNA topoisomerase I alpha
10/19/2006	US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2)
10/19/2006	US20060234294 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration
10/19/2006	US20060234213 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses
10/19/2006	US20060233820 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection
10/19/2006	US20060233818 Organic compounds
10/19/2006	US20060233816 Use of plant oil-bodies in vaccine delivery systems
10/19/2006	US20060233811 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/19/2006	US20060233800 Biological products
10/19/2006	US20060233793 Use of anti-cd100 antibodies
10/19/2006	US20060233787 Human cd3-specific antibody with immunosuppressive properties
10/19/2006	US20060233785 Immunointeractive molecules and uses thereof
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	US20060233743 Compositions and methods of therapy
10/19/2006	US20060233719 Delivery of antidepressants through an inhalation route
10/19/2006	US20060233710 Prevention and treatment for GVHD
10/19/2006	DE102005017592A1 Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem Dosage forms and compounds of Pyrimidinbiosyntheseinhibitoren to generate additional effects on the immune system
10/19/2006	CA2604758A1 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
10/19/2006	CA2604327A1 Pharmaceutical aerosol composition
10/19/2006	CA2604242A1 Immunomodulating compositions and uses therefor
10/19/2006	CA2604007A1 Use of fril proteins for reducing the production of pro-inflammatory cytokines
10/19/2006	CA2603779A1 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
10/19/2006	CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/19/2006	CA2600709A1 Use of cd25 antibodies in immunotherapy
10/18/2006	EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/18/2006	EP1712565A1 Cell death inducing agents
10/18/2006	EP1712563A1 Method of isolating monocytes
10/18/2006	EP1712553A2 Derivates of [6, 7-dihydro - 5H - imidazo[1,2- alpha]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of CAMS and leukointegrins
10/18/2006	EP1712232A1 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/18/2006	EP1712220A1 Pharmaceutical aerosol composition
10/18/2006	EP1711531A2 Neutralizing antibodies and methods of use thereof
10/18/2006	EP1711475A1 2-(phenylamino)-pyrimidin-5-amides as cannabinoid 2 receptors modulators for the treatment of immune or inflammatory disorders.

1 ... 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 ... 1172